Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Neurocognitive and familial moderators of psychiatric risk in velocardiofacial (22q11.2 deletion) syndrome: a longitudinal study.
[22q11.2 deletion syndrome]
Although
risk
for
psychosis
in
velocardiofacial
(
22
q
11
.
2
deletion
)
syndrome
(
VCFS
)
is
well
established
,
the
cognitive
and
familial
factors
that
moderate
that
risk
are
poorly
understood
.
A
total
of
75
youth
with
VCFS
were
assessed
at
three
time
points
,
at
3
-
year
intervals
.
Time
1
(
T
1
)
psychiatric
risk
was
assessed
with
the
Behavior
Assessment
System
for
Children
(
BASC
)
.
Data
reduction
of
BASC
scores
yielded
avoidance-
anxiety
and
dysregulation
factors
.
Time
2
(
T
2
)
neuropsychological
and
family
function
and
time
3
(
T
3
)
prodromal
/
overt
psychosis
were
assessed
.
Poisson
regression
models
tested
associations
between
T
3
positive
prodromal
symptoms
/
overt
psychosis
and
T
1
psychiatric
risk
,
T
2
cognitive
and
familial
factors
,
and
their
interactions
.
T
1
avoidance-
anxiety
ratings
predicted
T
3
prodromal
/
overt
psychosis
.
T
2
verbal
learning
scores
moderated
this
association
,
such
that
individuals
with
low
avoidance-
anxiety
scores
and
stronger
verbal
learning
skills
were
the
least
likely
to
demonstrate
prodromal
/
overt
psychosis
at
T
3
.
Low
scores
on
a
T
2
visual
vigilance
task
also
predicted
T
3
prodromal
/
overt
psychosis
,
independently
of
the
effect
of
T
1
avoidance-
anxiety
scores
.
T
1
dysregulation
scores
did
not
predict
T
3
prodromal
/
overt
psychosis
in
a
linear
manner
.
Instead
,
the
association
between
dysregulation
and
prodromal
/
overt
psychosis
was
amplified
by
T
2
levels
of
family
organization
,
such
that
individuals
with
low
dysregulation
scores
and
low
family
organization
scores
were
the
most
likely
to
exhibit
T
3
prodromal
/
overt
psychosis
.
Significant
moderators
of
psychiatric
risk
in
VCFS
include
verbal
learning
skills
as
well
as
levels
of
family
organization
,
carrying
implications
for
early
identification
and
preventative
treatment
of
youth
with
VCFS
at
highest
risk
for
psychosis
.